Società Acura Pharmaceuticals, Inc. Other OTC
Azioni
ACUR
US00509L8028
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Vendite per regione
USD in Milioni | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01/03/98 |
Albert Brzeczko
PRN | Corporate Officer/Principal | 67 | 01/02/09 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01/03/98 |
William Skelly
BRD | Director/Board Member | 73 | 01/05/96 |
Director/Board Member | 53 | 01/12/02 | |
George Ross
BRD | Director/Board Member | 82 | 01/01/08 |
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 66 349 283 | 10 428 580 ( 15,72 %) | 0 | 15,72 % |
Coordinate società
Acura Pharmaceuticals, Inc.
616 N. North Court Suite 120
60067, Palatine
+847 705 7709
http://www.acurapharm.com![Indirizzo Acura Pharmaceuticals, Inc.(ACUR)](https://cdn.zonebourse.com/static/address/34115591.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,43% | 124 Mrd | |
+19,81% | 114 Mrd | |
-23,74% | 19,42 Mrd | |
-18,14% | 16,2 Mrd | |
-19,97% | 15,31 Mrd | |
-49,33% | 14,19 Mrd | |
+57,08% | 14,32 Mrd | |
+7,95% | 14,31 Mrd | |
+126,04% | 11,29 Mrd |